Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Clinical trials sponsored by Jiangsu Alphamab Biopharmaceuticals Co., Ltd, explained in plain language.

Trials to join now! 4 Not yet recruiting 3 Not yet finished but already full! 1

New drug JSKN003 shows promise for Hard-to-Treat cancers

Disease control Ongoing

This study tests a new drug called JSKN003 in Chinese adults with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to find a safe dose and see if the drug can shrink tumors. About 725 participants will receive the drug by IV every three weeks.

Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control

Last updated May 17, 2026 04:13 UTC